Enterprise Trust & Investment’s GSK GSK Stock Holding History

Enterprise Trust & Investment’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$81K	Buy	1,487 +148	+11%	+$8.17K	0.03%	107
2022 Q1	$73K	Hold	1,339	–	–	0.03%	108
2021 Q4	$74K	Hold	1,339	–	–	0.03%	113
2021 Q3	$64K	Hold	1,339	–	–	0.03%	121
2021 Q2	$67K	Buy	1,339 +1,000	+295%	+$48K	0.03%	115
2021 Q1	$15K	Hold	339	–	–	0.01%	159
2020 Q4	$16K	Hold	339	–	–	0.01%	155
2020 Q3	$16K	Hold	339	–	–	0.01%	156
2020 Q2	$17K	Hold	339	–	–	0.01%	145
2020 Q1	$16K	Hold	339	–	–	0.01%	137
2019 Q4	$20K	Hold	339	–	–	0.01%	137
2019 Q3	$18K	Buy	+339	New	+$17.4K	0.01%	147

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Enterprise Trust & Investment's GSK Position: Q2 2022 in Review

Enterprise Trust & Investment increased its GSK (GSK) stake by 11% in Q2 2022, buying an estimated $8.17K and bringing the position to 1,487 shares worth $81K. The position accounts for 0.03% of the portfolio, ranked #107.

Enterprise Trust & Investment first reported a position in GSK in Q3 2019 and has held it in 12 quarters since. 900 funds tracked by Wall St. Rank hold GSK as of Q2 2022.

Enterprise Trust & Investment held 1,487 shares of GSK worth $81K as of Q2 2022.
Enterprise Trust & Investment bought 148 GSK shares in Q2 2022, an estimated $8.17K.
GSK made up 0.03% of Enterprise Trust & Investment's portfolio in Q2 2022, its #107 holding.
Enterprise Trust & Investment first reported a position in GSK in Q3 2019 and has held it in 12 quarters since.
900 funds tracked by Wall St. Rank held GSK as of Q2 2022.

Based on Enterprise Trust & Investment's 13F filing for Q2 2022, filed 22 Jul 2022.